Sulfonyl compounds which selectively modulate the CB2 receptor

Details for Australian Patent Application No. 2009296837 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Bartolozzi, Alessandra; Berry, Angela; Hickey, Eugene Richard; Ostermeier, Markus; Riether, Doris; Sauer, Achim; Thomson, David Smith; Wu, Lifen; Zindell, Renee M.; Amouzegh, Patricia; Blumire, Nigel James; East, Stephen Peter; Ermann, Monika; Khor, Someina; Mushi, Innocent

Agent Spruson & Ferguson

Pub. Number AU-A-2009296837

PCT Pub. Number WO2010/036630

Priority 61/100,077 25.09.08 US

Filing date 22 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 249/14 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/036630 Priority application(s): WO2010/036630

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296838-Sulfonyl compounds which selectively modulate the CB2 receptor

2009296822-Intelligent alert system and method